Your browser doesn't support javascript.
loading
Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer.
Cocco, E; Bellone, S; El-Sahwi, K; Cargnelutti, M; Casagrande, F; Buza, N; Tavassoli, F A; Siegel, E R; Visintin, I; Ratner, E; Silasi, D-A; Azodi, M; Schwartz, P E; Rutherford, T J; Pecorelli, S; Santin, A D.
Affiliation
  • Cocco E; Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT 06520-8063, USA.
Br J Cancer ; 101(2): 335-41, 2009 Jul 21.
Article in En | MEDLINE | ID: mdl-19536090
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Neoplasms / Serum Amyloid A Protein / Carcinoma, Papillary / Biomarkers, Tumor / Cystadenocarcinoma, Serous Type of study: Prognostic_studies Limits: Female / Humans / Middle aged Language: En Journal: Br J Cancer Year: 2009 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Neoplasms / Serum Amyloid A Protein / Carcinoma, Papillary / Biomarkers, Tumor / Cystadenocarcinoma, Serous Type of study: Prognostic_studies Limits: Female / Humans / Middle aged Language: En Journal: Br J Cancer Year: 2009 Document type: Article Affiliation country: Country of publication: